Article
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Sept 2024
Wirth Lori J, Brose Marcia S, Subbiah Vivek, Worden Francis, Solomon Ben, Robinson Bruce, Hadoux Julien, Tomasini Pascale, Weiler Daniela, Deschler-Baier Barbara, Tan Daniel S W, Maeda Patricia, Lin Yan, Singh Ravinder, Bayt Theresa, Drilon Alexander, Cassier Philippe A
Abstract excerpt
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.